Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sunesis Pharmaceuticals (SNSS) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (29)	9/22/2008 10:55:41 AM
From: rkrw	Respond to of 48

Thanks for posting. Impressive how many comments he got. Sure reads like snss problems were a thinly kept secret. I didn't realize the lead was inlicensed. One thing, maybe irrelevant, I always thought it was strange the ceo was ex-Alza, a drug delivery vet didn't seem like a good fit.

To: tuck who wrote (29)	9/27/2008 3:37:19 AM
From: nigel bates	Respond to of 48

Thanks from me as well. That was very instructive.

To: tuck who wrote (29)	9/29/2008 5:35:51 PM
From: scaram(o)uche	Respond to of 48

>> A lot of these founders (mostly biologists) who don't understand a thing about chemistry, latch onto some sexy idea they think will land them the Nobel Prize...... << Pukin' chemists, I hate 'em when they're correct. :-) (Thanks, Tuck, great insights! I was once interested in tethering, given an old biotech subsidiary at New Brunswick Scientific (now munched). Had little interest in snss after discussions of tethering with PB, and lost interest entirely when they did the usual desperation in-license).